Diadema Partners »

Tectonic Therapeutic shares owned by Diadema Partners

Quarter-by-quarter ownership of Tectonic Therapeutic (TECX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Tectonic Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Tectonic Therapeutic held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tectonic Therapeutic by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 100k 15.69

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Tectonic Therapeutic

FMR
BlackRock
Braidwell
Farallon Capital Management
Vanguard Group
5AM Venture Management
Point72 Asset Management
Prosight Management
Standard Life Aberdeen
Bollard
Citadel Advisors
Geode Capital Management
Pale Fire Capital SE
Polygon Management
Millennium Management

View all funds holding Tectonic Therapeutic